Summary: An HCP engagement program is a targeted, non-personal promotion strategy that maintains prescriber relationships and drives brand demand without a dedicated field sales force. In this case study, CareTria partnered with a top-five NYSE-listed pharmaceutical company to launch an HCP engagement program for a mature brand approaching patent expiration. The program exceeded all performance benchmarks within the first three call cycles, drove a 5% increase in overall market share, earned the brand’s entire promotional budget by year three, and sustained an eight-year partnership — all without field sales.
The Challenge: Protecting market share when a brand loses exclusivity
A top-five NYSE-listed pharmaceutical company was facing a challenge common in mature brand management: how to protect market share and maintain HCP loyalty when a product is approaching patent expiration and generic competition is entering the market.
The company had already made the strategic decision to eliminate its dedicated field sales force for the brand — cutting a significant commercial expense — but still needed to sustain prescriber relationships and drive product demand. The question was how to do more with less.
Without a sales force in the field, the brand was at risk of losing the physician touchpoints, sample availability, and office staff relationships that had historically protected its market position. The manufacturer needed a cost-effective solution that could fill the gap — and deliver results.
How an HCP engagement program replaced field sales and grew market share
CareTria deployed a targeted HCP engagement program specifically designed for brands navigating loss of exclusivity (LOE). The program delivered consistent product messaging and ensured reliable sample availability — two critical drivers of prescriber retention when generic alternatives are entering the market.
Rather than focusing exclusively on physicians, CareTria’s model engaged the entire medical office ecosystem. By building relationships with office staff and equipping them with the product knowledge and tools they needed, CareTria transformed them into informed brand advocates at the point of care.
Targeted messaging to high-value prescribers
CareTria focused outreach on physicians with a demonstrated preference for the brand and the highest potential to remain loyal through generic entry. Consistent, relevant messaging kept the product top-of-mind at the point of prescribing.
Reliable sample availability as a brand loyalty tool
Sample access is a proven driver of prescribing behavior, particularly for brands facing generic competition. CareTria managed end-to-end sample logistics, ensuring physicians and their staff always had product on hand to support patient initiation.
Office staff engagement and brand advocacy
By giving office staff the tools and product knowledge they needed, CareTria enabled them to facilitate patient initiation and support continued prescribing — helping protect the brand’s market position as generic competition intensified. Office staff became a frontline extension of the brand’s commercial presence.
HCP engagement program results: Market share growth, budget consolidation, and an eight-year partnership
The program delivered measurable, lasting impact across commercial and financial performance:
- Exceeded all client performance benchmarks within the first three call cycles: demonstrating immediate commercial impact from program launch
- 5% increase in overall market share: achieved without a field sales force, proving the program’s effectiveness as a standalone commercial channel
- By year three, the brand’s entire promotional budget was allocated exclusively to CareTria’s HCP Engagement program: a definitive signal of client confidence and demonstrated ROI
- Eight-year sustained partnership: the program became the brand’s sole commercial channel and continued delivering results throughout the brand’s life cycle
“Last week was the highest sales week since the end of last year. Net trade sales were up significantly. We are extremely pleased in what we see — the entire team’s effort and follow-through. There is nothing like coming in on Tuesday and seeing a significant uptake in the sales dollars.”
— Client, Top 5 NYSE-Listed Pharmaceutical Company
Why HCP engagement programs work for mature pharma brands
This case study demonstrates that a well-designed HCP engagement program can be a highly effective alternative to traditional field sales — particularly for mature brands managing loss of exclusivity. CareTria’s model reversed brand decline, grew market share, and earned an exclusive, eight-year partnership with a top pharmaceutical company.
The urgency is real. As brands lose exclusivity, generic erosion can happen quickly. Prescribers default to generics not out of preference, but because they have less information, fewer samples, and reduced brand presence in the office. A targeted HCP engagement program addresses each of those gaps — systematically, at scale, and at a fraction of the cost of a dedicated sales force.
What sets a strong HCP engagement program apart from generic outreach is the infrastructure behind it: targeted messaging to the right prescribers, reliable sample management, and office staff who are informed and equipped to advocate for the brand. Together, these components create a closed-loop commercial model where providers and their teams are not just reached, but retained — over years of continuous brand loyalty.
For pharma brands seeking to reduce commercial costs while maintaining or growing prescriber loyalty, a targeted HCP engagement strategy can deliver outsized, sustained results.
Contact us to learn how CareTria can provide a solution for you.
